HHS plans two new FDA deputy commissioners, one for AI-focused technology

Health and Human Services plans two new FDA deputy commissioners—one for technology/AI and one for drugs—reporting to FDA commissioner nominee Heidi Overton, with no final decisions yet; potential candidates include Jared Seehafer for tech and Kyle Diamantas for drugs. The move comes amid FDA scrutiny over drug approvals, food safety challenges, and expanding AI use, including the Elsa tool and a pending AI-regulation discussion.